News from scientific research
The importance of informing on new therapies for cardiomyopathies
We present 8 video presentations related to the AICARM Course in November 2024, created to provide clear, reliable, and useful information to those living with cardiomyopathy and their families.
Many cardiologists are studying the cardiotoxicity of oncology therapies to ensure effective oncology treatments for heart patients, according to the 2022 ESC guidelines.
Women are still underrepresented in clinical research. When testing new drugs, if the female sample is too underrepresented, it's impossible to fully document the benefits and potential risks to which women may be exposed.
Women are still underdiagnosed in cardiomyopathies. Diagnostic criteria that take gender differences into account are lacking, but research is changing this.
AI is an ally in medicine: it speeds up diagnoses and treatments, but requires clear rules and always human supervision.
Gender medicine emerged in the 90s, recognizing that gender influences diseases and symptoms. Today, it encompasses all specialties, but the path to true equity is still long.
Microplastics aren't just an environmental problem: an Italian study has found they can accumulate in arteries and increase the risk of heart attack and stroke. The article clearly explains where they are found, how they damage the heart, and what we can do every day to reduce exposure.
GLP-1 receptor agonists are drugs developed for diabetes that reduce appetite and weight, improve metabolism, and reduce cardiovascular risk. Effective against obesity, they should be used under medical supervision.
May is a special month for AICARM: we dedicate it to better understanding the benefits of nutrition in cardiomyopathy. However, we will not do it alone, but accompanied by one of the major international experts in this field, namely Dr. Sara Farnetti, with whom we will be able to discuss in the webinar on May 21st. Absolutely not to be missed.
Hereditary heart disease can cause patients to feel guilty, which can affect their quality of life, especially when it comes to parenting choices. This is also confirmed by a recent study published in the Journal of the American Heart Association, which analyzed the emotional impact of hereditary heart disease on 128 patients, with an average age of 51. With the right emotional and medical support, it is possible to overcome feelings of guilt, make informed choices, and build a life that reflects one's values.
